Skip to content

Public FDA record

Z-1263-2021: Heartspan Transseptal Needles, Catalog No. FND-019-02, Lot No. E1913645 consisting of an outer needle can

Recall record Z-1263-2021 for Merit Medical Systems, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1263-2021
Company in FDA record
Merit Medical Systems, Inc.
FDA record creation date
Mar 16, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The labeled needle tip curvature of specific lots of transseptal needles may not match the actual needle tip curvature. In the event that the incorrect needle is unknowingly used, an unintended anatomy puncture may occur, which is likely to require medical intervention.

Source facts

Action
Urgent Product Recall Notices were sent to consignees via FedEx overnight delivery beginning on January 19, 2021. The notification included product identification information, instructions to determine if any of the devices listed in the Customer Response Form (CRF) were within the consignees' faciltiies, quarantine them, and to discontinue distribution, and return product to Merit. Consignees were also requested to ensure that applicable personnel within their organizations were made aware of this field action; if the product has been further distributed to other facilities, institutions, or manufacturers, to ensure this notice is immediately shared with them and note the quantity distributed on the CRF. Consignees were requested to fill out, scan and email the completed Customer Response Form to Customer Service at response@merit.com within 10 business days, and to ensure all affected product shipped to the consignee has been accounted for on the CRF. Finally, customers were requested to immediately return all affected lots in their possession to Merit, per the instructions in the attached CRF. Consignees were informed that adverse events experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online at www.fda.gov/medwatch or by phone at 1-800-332-1088. Customers with questions may contact their Merit Sales Representative or Merit Customer Service at (801) 208-4381 | Hours: 6 am to 6 pm MST | Mon-Fri. Merit Sales Representatives with affected accounts were provided a courtesy notification via email which included a copy of the Recall Notice and CRF which was mailed to their accounts. The courtesy email also included instructions to assist their accounts with product return as requested by the account.
Initiated
2021-01-19
Root cause
Process control
Terminated
2022-05-17
Distribution
U.S. Consignees: VA, NE, Washington DC, MI, NY, KY, CA, TX, MD, AL, GA, UT, LA, CA, CT, PA, WA, MT and NJ. No government consignees. Also distributed OUS.
Recall number
Z-1263-2021
Recall status
Terminated
CDRH record ID
185772
FDA record created
2021-03-16
Recall event number
87306

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗